Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigating Harm: Assessing Preoperative Residual Gastric Volumes to Risk Stratify Patients Administering Semaglutide

NCT06263595 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT06263595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06263595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigating Harm: Assessing Preoperative Residual Gastric Volumes to Risk Stratify Patients Administering Semaglutide
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Completed
Start date
May 31, 2024
Completion date
May 16, 2025
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary aspiration